ISID NEWS • December 2011 8
ISID Small Grant Program Report
Molecular Epidemiology of Hepatitis B Virus in Minangkabau Ethnic Group of West Sumatera, Indonesia
Marlinang D. Siburian,1 Mariana D.B. Intan,1 Ismail,1 Arnelis,2 Nasrul Zubir,2 Erlys B. Julianto,3 Andi Utama1
1MochtarRiadyInstituteforNanotechnology•Tangerang,Banten,Indonesia2M.DjamilHospital,Padang•WestSumatera,Indonesia3BloodTransfusionUnit,RedCrossPadang•WestSumatera,Indonesia
BackgroundHepatitisBvirus(HBV)infectionisassociatedwithadiverseclinicalspectrumofliverdamagerangingfromasymptomaticcarriers(AC),chronichepatitis(CH),livercirrhosis(LC),andhepatocellularcarcinoma(HCC).WHOestimatedabout2billionpeopleworldwidehavebeeninfectedbythevirusand350millionpeoplelivewithchronicHBVinfection.Indonesiawasreportedtohaveintermediatetohighendemicity[1].
Currentlythereareeightestablished(A–H)andtwoputative(I–J)HBVgenotypeswithdis-tinctgeographicaldistributions.GenotypeBandCarehighlyendemicinEastAsiaincludingIndonesia.TherearefourHBVgenotypesfoundinIndonesia(A–D),wheregenotypeBhasbeenfoundasthemajorgenotype[1–5].HBVgenotypeshavebeenreportedtoberelatedwithseverityofliverdisease.Forexample,genotypeChashigherdisease-inducingcapacitycomparedtogenotypeBinEastAsiancountriesthroughhighincidenceofcorepromotermutation[6–8].
MinangkabauisoneofthefourmajorethnicgroupsinIndonesiawithpopulationofapproxi-mately5.3million.TheyoriginallyresideintheWestSumateraprovince.PadangisthecapitalcityofWestSumaterawithapopulationofover833,000(census2010).ApreliminarystudyonHBVmolecularepidemiologyofMinangkabauethnicgroupprevaileddifferentprevalenceofHBVgenotypescomparetoIndonesianpopulationingeneral[4].Thisstudyaimedtofur-theranalyzetheprevalenceofHBVgenotypeinPadangpopulationandspecificallyMinangk-abauethnicgroup.
Materials and MethodsBloodsampleswerecollectedfromM.DjamilHospitalPadang,WestSumateraandBloodTransfusionUnit,RedCrossPadang,WestSumatera.Thesamplesweretakenfrom147blooddonors,and42liverdiseasepatientscomprisedof16CH,22LC,and4HCCpatients.Informedconsentwasobtainedfromeachparticipant.HBsAgtestforallsampleswereperformedbyacommerciallyavailableELISAkit(AbbottLaboratories,Chicago,IL).HBVDNAwasextractedfrom200μLplasmausingtheQIAampDNAbloodminikit(Qiagen,Hilden,Germany)accordingtothemanufacturer’sinstructions.HBVgenotype,subgenotypeandBCPdoublemutationweredeterminedaspreviouslydescribed[5,9].StatisticalanalyseswereperformedusingSPSS17.0softwareforWindows(SPSSInc.,Chicago,IL,USA)andP <0.05wasconsideredsignificant.
Results and DiscussionThestudyincludedatotalof189sampleswithpositiveHBsAgtest,165malesand24females.Themeanageofsubjectwas37.5±11.6yearsold.Of189samples,140(74.1%)and99(52.4%)sampleswerepositiveforgenotypingandsubgenotyping,respectively.GenotypeCwasfoundin84(60.0%)samples,genotypeBwasfoundin49(35.0%)samples,andmixgenotypesBandCwasfoundin7(5.0%)samples.Basedonitsethnicity,thesamplesweredividedintotwogroups:theMinangkabauethnicgroupandotherethnicsgroup,whichincludestheJavanese,Sundanese,Batak,andotherSumateraneseethnics.From189samples,98(70.0%)samplesbelongtoMinangkabauethnicgroup.Male/femaleratioandmeanageofthetwogroupsaresimilar.RatioofgenotypeBandCandmixgenotypeofB/CforMinangkabauethnicgroupandotherethnicsgroupwere19.4%:77.6%:3.1%and71.4%:19.1%:9.5%,respectively.Thegenotypedistributionbetweenthetwogroupsweresignifi-cantlydifferent(P<0.001).ThemajorsubgenotypesinthesamplesfromPadangwereC1(62.6%)
Marlinang D. Siburian
Ms. Siburian is a junior researcher
at the Mochtar Riady Institute
for Nanotechnology, Indonesia.
Her particular interest is in
Molecular epidemiology.
She has been working on
Molecular epidemiology of
Hepatitis B Virus and its
association with liver disease
in Indonesian population under
the supervision of Andi Utama
Ph.D and has co-authored in
some of the publications.
This research was supported with a grant from the International Society for Infectious Diseases (ISID).
continued on next page
ISID NEWS • December 2011 9
ISID Small Grant Program Report continued
followedbyB3(24.2%)andB7(4.0%).IfwecomparedtheHBVgenotypeprevalencebetweenMinangkabauandotherethnicsgroups,itwasfoundthatintheMinangkabauethnicgroupthesubgenotypeC1(76.4%)wasmoredominantthansubgenotypeB3(18.1%),whileintheotherethnicgroupthemajorsubgenotypewasB3(40.7%)followedbysubgenotypesC1(25.9%)andB7(14.8%).
ThepresentstudyshowedthedifferenceofHBVgenotypeandsubgenotypedistributioninMinangkabauethniccomparedtothoseinIndonesianpopulationingeneral[4,5].HBVgenotypeCwithmajorityofsubgenotypeC1wasfoundasthemajorHBVgenotypeinPadang,specificallyinMinangkabauethnicgroup.AlthoughanotherstudyreportedthatHBVgenotypeCwasalsoprevalentintheeasternpartofIndonesia(MoluccasandPapua),themainsubgenotypesinthisareawereC5andC6[4,10],differentwithgenotypeCfoundinMinangkabauethnic.Inothercountries,HBVgenotypeCismoreprevalentinEastAsia,suchasinChinaandTaiwan.LongitudinalcohortstudiesinTaiwandemonstratedthatHBVgenotypeCisanindependentriskfactorforHCCdevelopmentandisassociatedwithahigherriskofreactivationofhepatitisBandprogressiontocirrhosisthanHBVgenotypeB[11-13].Longitudinalcohortstudyneedstobeperformedinordertoinvestigatetheassocia-tionofHBVgenotypeCandriskofHCCinMinangkabaupopulation.
ConclusionsTheHBVgenotypedistributioninthepopulationofMinangkabauethnicisdifferentthanthatofotherIndonesianHBVcarrieringeneral.MinangkabauethnicgrouphashigherprevalenceofHBVgenotypeCthanotherethnicsgroup(77.6%vs19.1%).SubgenotypeC1andB3arethemajorsubgenotypesfoundinthisethnicgroup.ThesepreliminaryresultsindicatethattheMinangkabauethnicgroupmaybeathigherriskofdevelopingsevereliverdisease.
This study was supported by a grant from the International Society for Infectious Diseases (ISID) under the Small Grants Program. We thank Rama Dhenni for the assistance in blood sample collections.
References1.SastrosoewignjoRI,SandjajaB,OkamotoH.MolecularepidemiologyofhepatitisBvirusinIndonesia.J Gastroenterol Hepatol 1991;6:491–498.
2.LusidaMI,Surayah,SakugawaH,etal.GenotypeandsubtypeanalysesofhepatitisBvirus(HBV)andpossiblecoinfectionofHBVandhepatitisCvirus(HCV)orhepatitisDvirus(HDV)inblooddonors,patientswithchronicliverdiseaseandpatientsonhemodialysisinSurabaya,Indonesia.Microbiol Immunol 2003;47:969–975.
3.NurainyN,MuljonoDH,SudoyoH,MarzukiS.GeneticstudyofhepatitisBvirusinIndonesiarevealsanewsubgenotypeofgenotypeBineastNusaTenggara.Arch Virol 2008;153:1057–1065.
4.Mulyanto,DepamedeSN,SurayahK,TsudaF,IchiyamaK,TakahashiM,OkamotoH.AnationwidemolecularepidemiologicalstudyonhepatitisBvirusinIndonesia:identificationoftwonovelsubgenotypes,B8andC7.Arch Virol 2009;154:1047–1059.
5.UtamaA,PurwantomoS,SiburianMD,etal.HepatitisBvirussubgenotypesandbasalcorepromotermutationsinIndonesia.World J Gastroenterol2009;15:4028–4036.
6.Kao,JH.HepatitisBviralgenotypes:clinicalrelevanceandmolecularcharacteristics.J Gastroenterol Hepatol 2002;17:643–650.
7.OritoE,IchidaT,SakugawaH,etal.GeographicaldistributionofhepatitisBvirus(HBV)genotypeinpatientswithchronicHBVinfectioninJapan.Hepatology2001;34:590–594.
8.HuyTT,UshijimaH,WinKM,etal.HighprevalenceofhepatitisBviruspre-Smutantincountrieswhereitisendemicanditsrelationshipwithgenotypeandchronicity.J Clin Microbiol2003;41:5449–5455.
9.UtamaA,OctaviaTI,DhenniR,MiskadUA,YusufI,TaiS.HepatitisBvirusgenotypes/subgenotypesinvoluntaryblooddonorsinMakassar,SouthSulawesi,Indonesia.Virol J2009;6:128.
10.LusidaMI,NugrahaputraVE,Soetjipto,etal.NovelsubgenotypesofhepatitisBvirusgenotypesCandDinPapua,Indonesia.J Clin Microbiol2008;46:2160–2166.
11.ChanHL,HuiAY,WongML,TseAM,HungLC,WongVW,SungJJ.GenotypeChepatitisBvirusinfectionisassociatedwithanincreasedriskofhepatocellularcarcinoma.Gut2004;53:1494–1498.
12.ChuCM,LiawYF.GenotypeChepatitisBvirusinfectionisassociatedwithahigherriskofreactivationofhepatitisBandprogressiontocirrhosisthangenotypeB:alongitudinalstudyofhepatitisBeantigen-positivepatientswithnormalaminotransferaselevelsatbaseline.J Hepatol2005;43:411–507.
13.YangHI,YehSH,ChenPJ,etal.AssociationsbetweenhepatitisBvirusgenotypeandmutantsandtheriskofhepatocellularcarcinoma.J Natl Cancer Inst2008;100:1134–1143.
ISID Small Grant Report of
Marlinang D. SiburianMolecular Epidemiology of Hepatitis B Virus in
Minangkabau Ethnic Group of West Sumatera, Indonesia
This research was supported with a grant from the International Society for Infectious Diseases (ISID).